Pinnacle Wealth Management Advisory Group LLC purchased a new position in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 260,000 shares of the company's stock, valued at approximately $751,000. Pinnacle Wealth Management Advisory Group LLC owned about 0.24% of Definitive Healthcare as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Irenic Capital Management LP lifted its position in Definitive Healthcare by 9.2% in the 4th quarter. Irenic Capital Management LP now owns 7,003,194 shares of the company's stock valued at $28,783,000 after acquiring an additional 590,009 shares in the last quarter. Susquehanna Fundamental Investments LLC bought a new position in shares of Definitive Healthcare during the 4th quarter valued at $1,181,000. Two Sigma Investments LP lifted its holdings in shares of Definitive Healthcare by 2,383.1% during the 4th quarter. Two Sigma Investments LP now owns 285,555 shares of the company's stock valued at $1,174,000 after buying an additional 274,055 shares during the period. Pinnacle Associates Ltd. bought a new position in shares of Definitive Healthcare during the 1st quarter valued at $751,000. Finally, Sone Capital Management LLC bought a new position in shares of Definitive Healthcare during the 4th quarter valued at $953,000. Hedge funds and other institutional investors own 98.67% of the company's stock.
Wall Street Analyst Weigh In
DH has been the subject of several analyst reports. BTIG Research lowered Definitive Healthcare from a "buy" rating to a "neutral" rating in a research note on Friday, May 9th. Wall Street Zen raised shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, June 21st. Finally, The Goldman Sachs Group boosted their price objective on shares of Definitive Healthcare from $3.00 to $3.40 and gave the company a "neutral" rating in a report on Monday, May 12th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company. According to MarketBeat, Definitive Healthcare has an average rating of "Hold" and an average target price of $4.77.
Check Out Our Latest Stock Analysis on DH
Definitive Healthcare Trading Down 3.2%
Shares of NASDAQ:DH traded down $0.13 during mid-day trading on Friday, reaching $3.78. 295,280 shares of the company were exchanged, compared to its average volume of 851,188. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.75 and a quick ratio of 1.75. The firm has a market cap of $561.12 million, a price-to-earnings ratio of -0.86, a P/E/G ratio of 6.73 and a beta of 1.64. The firm's 50-day simple moving average is $3.80 and its 200 day simple moving average is $3.63. Definitive Healthcare Corp. has a 1 year low of $2.15 and a 1 year high of $5.68.
Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.02 by $0.03. Definitive Healthcare had a negative net margin of 206.05% and a positive return on equity of 3.69%. The company had revenue of $59.19 million during the quarter, compared to analysts' expectations of $56.20 million. During the same quarter last year, the company posted $0.08 EPS. The firm's revenue was down 6.8% compared to the same quarter last year. Equities research analysts forecast that Definitive Healthcare Corp. will post 0.16 EPS for the current year.
Definitive Healthcare Profile
(
Free Report)
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Featured Stories

Before you consider Definitive Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.
While Definitive Healthcare currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.